diaDexus
Home About diaDexus Products & Technology Investors & Media Careers Contact us
Welcome

diaDexus is committed to providing novel diagnostic products with high clinical value to address significant unmet medical needs in the cardiovascular field.

Our Products

The PLAC® Test is the only blood test cleared by the FDA to aid in assessing risk for both coronary heart disease (CHD) and ischemic stroke associated with atherosclerosis.

more info | visit site

Latest News

July 28, 2010
VaxGen and diaDexus Complete Merger

May 28, 2010
VaxGen to Acquire diaDexus in a Stock-for-Stock Merger Under Revised Terms

May 19, 2010
Large Meta-Analysis Further Validates Benefit of Measuring Lp-PLA2 for Coronary Heart Disease and Ischemic Stroke Risk Assessment

April 14, 2010
VAXGEN TO ACQUIRE DIADEXUS IN A STOCK-FOR-STOCK MERGER
diaDexus will use cash to fund continued adoption of the PLAC® Test

News Archive